Wall Street Gets It Backward On Amgen Cholesterol Drug
Forbes,
Shares of Aegerion Pharmaceuticals have risen 200% since October on hopes that the company’s drug Juxtapid, a treatment for a…
Phase II Clinical Research Design in Cardiology
Overview of attention for article published in Circulation, April 2013
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (89th percentile)
-
Good Attention Score compared to outputs of the same age and source (70th percentile)
Readers on
- mendeley
- 48 Mendeley